OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.600
+0.010 (0.63%)
At close: May 19, 2026, 4:00 PM EDT
1.610
+0.010 (0.63%)
After-hours: May 19, 2026, 4:04 PM EDT
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $83.97 million as of May 19, 2026. Its market cap has increased by 81.59% in one year.
Market Cap
83.97M
Enterprise Value
79.93M
1-Year Change
81.59%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since the IPO on September 4, 2013, OKYO Pharma's market cap has decreased from $141.20M to $83.97M, a decrease of -40.53%. That is a compound annual growth rate of -4.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 83.44M | 7.18% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -48.55% |
| Dec 10, 2021 | 82.51M | 4.85% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 90.60M |
| Oncolytics Biotech | 90.00M |
| PolyPid | 89.88M |
| Anixa Biosciences | 89.52M |
| Rani Therapeutics Holdings | 88.27M |
| Biomea Fusion | 88.21M |
| Fortress Biotech | 84.04M |
| NeurAxis | 83.41M |